Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Caribou Biosciences, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$4.82 - $8.26 $9,331 - $15,991	-1,936 Reduced 4.38%	42,266 $217,000
Q4 2023 Feb 08, 2024	BUY	$3.58 - $6.25 $158,243 - $276,262	44,202 New	44,202 $253,000
Q1 2023 May 08, 2023	BUY	$4.3 - $7.78 $9,374 - $16,960	2,180 Added 7.88%	29,861 $158,000
Q4 2022 Feb 07, 2023	BUY	$5.57 - $11.01 $154,183 - $304,767	27,681 New	27,681 $173,000
Q2 2022 Aug 04, 2022	SELL	$5.1 - $9.74 $79,825 - $152,450	-15,652 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.42 - $15.32 $14,566 - $26,503	1,730 Added 12.43%	15,652 $144,000
Q4 2021 Feb 07, 2022	BUY	$14.59 - $23.26 $203,121 - $323,825	13,922 New	13,922 $213,000

Others Institutions Holding CRBU

# of Institutions

135

Shares Held

52.6M

Call Options Held

148K

Put Options Held

70.7K

Black Rock Inc. New York, NY

6.95M
Shares

$14 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.62M
Shares

$9.33 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

4.57M
Shares

$9.23 Million
0.0% of portfolio
Pfm Health Sciences, LP San Francisco, CA

4.31M
Shares

$8.7 Million
0.49% of portfolio
Kynam Capital Management, LP Princeton, NJ

2.36M
Shares

$4.76 Million
0.38% of portfolio

View Full List

About Caribou Biosciences, Inc.

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $123M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

More about CRBU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account